Overview
You can access the company’s website by clicking here.
Fundamentals
Price
Research History
-
08 Mar 2019 1 min read
International Biotechnology trust – Beating the odds
International Biotechnology Trust – Beating the odds Strategic positioning in mid-2018 helped International Biotechnology Trust (IBT) beat its benchmark over the past six months and close its discount to net asset value (NAV). This continued its outperformance of the US Nasdaq Biotechnology Index (NBI) over three and five years. Active management of the portfolio and […]
-
1 min read
International Biotechnology Trust – Beating the odds
International Biotechnology Trust – Beating the odds Strategic positioning in mid-2018 helped International Biotechnology Trust (IBT) beat its benchmark over the past six months and close its discount to NAV. This continued its outperformance of the US Nasdaq Biotechnology Index (NBI) over three and five years. Active management of the portfolio and an increased focus […]
-
11 Dec 2017 2 min read
QuotedData’s economic round up – December 2017
QuotedData’s economic round up – December 2017 – is a collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or […]
News
-
03 Jul 2019 1 min read
Morphosys receives milestone as GSK advances RA antibody
Morphosys receives milestone as GSK advances RA antibody – German biotech MorphoSys (NASDAQ: MOR), a holding of International Biotechnology Trust (IBT), has received a €22m milestone payment from its licensing partner GlaxoSmithKline (GSK) in connection with the start of a Phase III trial programme with otilimab (formerly MOR103/GSK3196165) in rheumatoid arthritis (RA). GSK will conduct four […]
-
27 Feb 2019 20 min read
Law Debenture Corporation protects against almost 40% of market decline
Law Debenture Corporation (LWDB) has announced its annual results for the year ended 31 December 2018. For those not familiar with its structure, LWDB is a unique combination of an equity portfolio and independent professional services business. Key highlights for the Group, the equity portfolio and the independent professional services business are provided below, but […]
-
10 Dec 2018 8 min read
Scottish Investment Trust provides 35th consecutive year of dividend increase
Scottish Investment Trust (SCIN) has announced its final results for the year ended 31 October 2018. During the year, the share price total return was +1.9% and the NAV total return was +1.1%. SCIN does not have a formal benchmark but it says that, by way of comparison, the sterling total return of the international […]
-
14 Aug 2018 2 min read
BG-backed Orchard raises $150m on the back of GSK deal
BG-backed Orchard raises $150m on the back of GSK deal Baillie Gifford-backed US-UK gene therapy company Orchard Therapeutics has raised $150m in a Series C financing just four months after acquiring GlaxoSmithKline’s portfolio of investigational and approved rare disease gene therapies. The financing was led by Deerfield Management, a leading US healthcare investor, and included more than […]
-
11 Dec 2017 5 min read
Scottish Investment Trust held back by contrarian style this year
Scottish Investment Trust held back by contrarian style this year – Scottish Investment Trust says that, during the 12 months to 31 October 2017, the share price total return was 12.8% and the net asset value per share (NAV) total return (with borrowings at market value) was 11.0%. These returns include a 1.4p uplift from […]
-
25 Sep 2017 5 min read
Large cap focus restrains City of London
Large cap focus restrains City of London – City of London Investment Trust has published results for the year ended 30 June 2017. Its returns fell behind those of peers and index benchmarks over the period. City of London’s net asset value total return was 14.5% which was 3.3% behind the size weighted average over […]
-
21 Apr 2017 8 min read
Aurora’s manager gets behind Mike Ashley
Aurora has announced its results for the 10-month period from 29 February 2016 to 31 December 2016. Its chairman, Lord Flight (pictured), explains that reason for the ‘short year’ is to align Aurora’s accounting period with that of its Investment Manager, Phoenix Asset Management Partners, who have been in place for approximately 15 months, following […]
-
24 Nov 2016 3 min read
Invesco Income Growth hit by a few profit warnings
Invesco Income Growth reports that the total return on net asset value over the half year to 30 September 2016 was 9.1%, it was a little behind their benchmark, which returned 12.9%. Nonetheless the share price’s total return was better, at 11.6%, thanks to the narrowing of the discount. The Board is declaring a second interim dividend of […]
-
22 Nov 2016 3 min read
Schroder Income Growth raises dividend for 21st consecutive year
Schroder Income Growth Fund has published its annual financial report for the year ended 31 August 2016. A total return of 8.4% for the net asset value compared unfavourably to a total return of 11.7% for the FTSE All-Share Index. The share price produced a negative total return for the year of 0.8%, reflecting a widening in […]
-
16 Nov 2016 3 min read
An “annus horribilis” for Standard Life Equity Income
Standard Life Equity Income says that, taken in isolation, its headline numbers for the year to 30 September 2016 do not make pleasant reading. The Net Asset Value Total Return for the year was 0.9%. By contrast, the FTSE All-Share Index returned 16.8%. Unsurprisingly, the share price has suffered over the last twelve months. The discount widened […]
-
21 Oct 2016 2 min read
Manchester & London performance improves
Manchester & London reports that, for the year ended 31 July 2016, its NAV increased by 19.8% which they compare to a 4.0% return on the Dow Jones U.K. Total Stock Market Total Return Index. The discount the Shares trade at to their Net Asset Value per Share has widened by 2.2 per cent during […]
-
25 Jul 2016 1 min read
Temple Bar hit by Brexit
During the six month period to 30 June 2016 Temple Bar generated a net asset value total return of 3.8%, slightly underperforming the benchmark FTSE All Share total return of 4.3%. A notable feature of the period was the long awaited out-performance of larger companies relative to their smaller brethren; the FTSE 100 Index delivered […]
-
16 Jun 2016 8 min read
Aurora publishes first annual report since new manager
Aurora Investment Trust has published its first annual report since the management of the company was passed to Phoenix Asset Management. The report covers the year ended 29 February 2016 – Phoenix took up the reins on 28 January 2016 so most of the performance of the fund over this period is attributable to the […]
-
26 May 2016 6 min read
Edinburgh Investment Trust sees strong benefits from its Tobacco holdings
The Edinburgh Investment Trust, managed by Mark Barnett (pictured), has announced its annual results for the year ended 31 March 2016. During the year, the trust produced an NAV total return +4.6% (with dent at market value) versus a negative return of 3.9% for the trust’s benchmark, the FTSE All-Share Index. The company’s share price total […]
-
24 Dec 2015 4 min read
Schroder UK Growth mildly outperforms benchmark
Schroder UK Growth Fund has announced its interim results for the six-months ended 31 October 2015. During the period, the Company’s NAV produced a total return of -5.3%, marginally outperforming its benchmark, the FTSE All-Share Index, which provided a total return of -5.7%. The share price produced a total return of -5.7%. The company has […]
-
30 Oct 2015 2 min read
Manchester & London cuts dividend as performance stabilises
Manchester & London has published results for the year ended 31 July 2015. These show that the fund just outperformed its benchmark, the Dow Jones U.K. Total Stock Market Total Return Index, returning 5.0% on net assets vs. 4.8% for the index. The Directors are proposing a final ordinary dividend per share of 1.70p and […]
-
09 Jun 2015 3 min read
JPMorgan European benefits from strong stock selection
JPMorgan European has announced results for the year ended 31 March 2015. The report says that both the growth and income pool outperformed their benchmark (MSCI Europe ex UK) over the year with the Growth shares producing a total return of +14.5% and the Income shares a total return of +15.4%, compared with 7.0% for the […]
-
19 Jan 2015 1 min read
Bankers outperformance helped by Apple
Bankers Investment Trust has published its results for the year that ended on 31 October 2014. The net asset value rose by 1.5% while the FTSE All-Share Index fell by 2.3%. The full year dividend was increased by 4.7% to 14.8p and the Board is forecasting a dividend of at least 15.5p for the current […]
-
21 Nov 2014 2 min read
Perpetual Income & Growth beats benchmark
PLI : Perpetual Income & Growth beats benchmark Over the six months to the end of September Perpetual Income & Growth generated a 2.2% return on net assets. There was a small widening of the discount so the share price return was 1.6%. By contrast the return on the company’s benchmark was 1.2%. The dividend was […]
